Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Filings indexed 817 across all filing types
Latest filing 2016-03-17 Proxy Solicitation & In…
Country IT Italy
Listing XMIL DIA

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Modulo di delega Assemblea degli Azionisti 28 aprile 2016
Proxy Solicitation & Information Statement Classification · 99% confidence The document text is titled 'DELEGA PER L'INTERVENTO IN ASSEMBLEA' (Proxy for Attendance at the Meeting) and contains a form for shareholders to delegate their voting rights for the DiaSorin S.p.A. Shareholders' Meeting scheduled for April 28, 2016. This material is directly related to soliciting shareholder votes and providing necessary information for participation in a general meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not an AGM presentation (AGM-R), a full annual report (10-K), or a declaration of voting results (DVA), but rather the mechanism used *before* the meeting to assign voting power.
2016-03-17 Italian
DiaSorin S.p.A.-Explanatory Reports Shareholders' Meeting April 28, 2016
AGM Information Classification · 100% confidence The document is titled "SHAREHOLDERS' MEETING DIASORIN S.p.A." and explicitly details the 'Agenda' for an Ordinary Shareholders' Meeting scheduled for April 28/29, 2016. The agenda items include motions for the approval of financial statements, election of the Board of Directors and Statutory Auditors, and resolutions concerning a Stock Option Plan and treasury shares. This content—notices, agendas, and explanatory reports for a shareholder meeting—is characteristic of materials prepared for or presented at an Annual General Meeting (AGM). Although it contains financial reporting items (like approval of financial statements), the primary context and structure point to the meeting itself, making 'AGM-R' the most appropriate classification over '10-K' or 'ER'.
2016-03-17 English
DiaSorin S.p.A.-Relazioni Illustrative Assemblea degli Azionisti 28 aprile 2016
AGM Information Classification · 100% confidence The document is titled "ASSEMBLEA DEGLI AZIONISTI DIASORIN S.p.A." (Shareholders' Meeting of Diasorin S.p.A.) and contains "RELAZIONI ILLUSTRATIVE E PROPOSTE DI DELIBERA" (Explanatory Reports and Proposals for Resolution). It explicitly details the 'Ordine del Giorno' (Agenda) for an upcoming meeting on April 28/29, 2016, covering items like approval of the financial statements, remuneration reports, appointment of the Board of Directors and Statutory Auditors, and authorization for share buybacks. This content is characteristic of the preparatory materials sent to shareholders before an Annual General Meeting (AGM) to inform their voting decisions. This aligns perfectly with the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, or potentially Proxy Solicitation & Information Statement (PSI), but given the focus on the meeting notice and detailed proposals, AGM-R is the most specific fit for the core purpose of the document, which is to prepare for the AGM.
2016-03-17 Italian
Interim Financial Report Third Quarter 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT ON OPERATIONS OF THE DIASORIN GROUP AT SEPTEMBER 30, 2015'. It contains comprehensive financial statements, including the consolidated income statement, statement of financial position, and cash flow analysis for the third quarter of 2015. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-11-19 English
Resoconto Intermedio di Gestione al 30 settembre 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RESOCONTO INTERMEDIO DI GESTIONE' (Interim Management Report) for DiaSorin for the period ending September 30, 2015. It contains comprehensive financial statements, including the consolidated income statement, balance sheet, and cash flow statement, as well as management's analysis of the results. It is a full quarterly report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). 9M 2015
2015-11-11 Italian
DiaSorin 2015 semiannual financial report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semiannual Financial Report' for the DiaSorin Group for the period ending June 30, 2015. It contains comprehensive financial statements, including the consolidated income statement, statement of financial position, cash flows, and notes to the financial statements. As it covers a period shorter than a full fiscal year and includes substantive financial data, it is classified as an Interim/Quarterly Report. H1 2015
2015-09-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.